Statins in Perimenopause and Menopause
- Dr. Jen
- 2 days ago
- 3 min read
What Midlife Women Need to Know About Muscle Loss, Insulin Resistance, and Diabetes Risk
If you are in perimenopause or menopause and have been prescribed a statin for cholesterol, this conversation matters.
Statins can be helpful in the right patient, if prescribed correctly. But for midlife women, the risk-benefit conversation must include muscle preservation, insulin resistance, and diabetes risk — especially during the menopause transition. There is also the question of if women really need a statin or if they just need their estradiol optimized.
Perimenopause is already a time of:
Declining muscle mass
Rising insulin resistance
Increased visceral fat
Higher cardiovascular risk
Adding a medication that may influence muscle and glucose metabolism deserves thoughtful discussion.
1. Statins and Muscle Loss in Midlife Women
Muscle is not cosmetic. It is metabolic protection.
During perimenopause and menopause, women naturally lose lean mass at an accelerated rate. This contributes to:
Slower metabolism
Insulin resistance
Higher fall risk
Reduced strength
Increased cardiometabolic risk
A 2025 UK Biobank analysis involving nearly 300,000 participants found statin use was associated with lower grip strength and lower appendicular lean mass at baseline. Over approximately 10 years, continuous statin use was associated with faster declines in both strength and lean mass compared to never users
Why this matters for menopausal women:
Women start with lower baseline muscle mass compared to men. Loss of lean mass during menopause is already significant. Any therapy that potentially accelerates decline should be monitored carefully.
2. Statins and Type 2 Diabetes Risk in Midlife
Insulin resistance rises during perimenopause due to:
Estrogen fluctuation
Changes in body composition
Increased visceral adiposity
A 2025 prospective cohort analysis across three large studies followed participants for up to 23 years and found statin users had a higher risk of developing type 2 diabetes compared with non users. Risk increased with longer duration of statin use and varied by statin type and potency
This is especially relevant for:
Women with prior gestational diabetes
PCOS history
Central weight gain
Family history of diabetes
Prediabetes in midlife
Menopause alone increases diabetes risk. Layering statin therapy may require closer metabolic monitoring.
3. Statins and Insulin Resistance
A 2023 systematic review evaluating statins and insulin intolerance concluded that statin therapy may reduce insulin sensitivity and increase insulin resistance
In midlife women, insulin resistance drives:
Abdominal fat gain
Elevated triglycerides
Fatty liver risk
Fatigue
Brain fog
Inflammation
Insulin sensitivity is foundational to hormonal stability in perimenopause and menopause.
4. Women May Experience Side Effects Differently
Sex-based reviews show women are more likely to experience statin-associated muscle symptoms and are more likely to discontinue therapy due to side effects
Additionally, Women’s Health Initiative data previously demonstrated increased incident diabetes risk among postmenopausal women using statins
While cardiovascular prevention is critical, therapy in women must account for:
Hormonal shifts
Muscle vulnerability
Metabolic changes unique to menopause
Hold that Script Pad!
In perimenopause and menopause, the statin conversation should include:
Baseline fasting glucose, A1c, and fasting insulin
Monitoring triglycerides and waist circumference
Strength training prescription
Protein optimization
Vitamin D and thyroid status
Individual statin selection and dose (water soluble, weekly dosing has been studied)
One size does not fit all.
A Midlife-Specific Approach to Cholesterol
Cholesterol in midlife is complex.
During perimenopause, LDL often rises transiently due to hormonal changes. That does not automatically equal pathology.
A comprehensive risk assessment may include:
ApoB
Lipoprotein(a)
hs-CRP
Coronary artery calcium scoring
Insulin resistance markers
Coronary Calcium Score CT
Treat the whole physiology, not just the LDL number.
Bottom Line for Perimenopausal and Menopausal Women
If you are:
In your 40s or 50s
Experiencing weight gain, muscle loss, or fatigue
Concerned about cholesterol
Navigating perimenopause or menopause
You deserve a risk-benefit plan that protects:
Your heart
Your muscle
Your metabolism
Your hormonal stability
Statins can play a role in prevention. But muscle and metabolic protection must be part of the plan.
Work With Me
If you are a perimenopausal or menopausal woman who wants a personalized cardiovascular and metabolic strategy — not just a prescription — apply to work with my clinic. We build prevention plans that preserve muscle, protect insulin sensitivity, and support hormone balance in midlife. I also have courses and a community availble for women. You are not alone in your health journey!
references
Comments